ESMO 2019 | The immunotherapy NSCLC revolution

Solange Peters

Solange Peters, MD, PhD, University Hospital Vaudois, Lausanne, Switzerland, discusses how immunotherapies are a revolution for the treatment of non-small cell lung cancer (NSCLC), and the issue of their accessibility. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video